Steven Cohen Zymeworks Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.43 $1.13 Million - $1.81 Million	244,000 New	244,000 $1.5 Million
Q2 2022 Aug 15, 2022	SELL	$4.82 - $7.7 $3.69 Million - $5.89 Million	-765,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $90,000 - $254,700	15,000 Added 2.0%	765,500 $5.01 Million
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $11.4 Million - $22 Million	750,500 New	750,500 $12.3 Million
Q3 2021 Nov 15, 2021	SELL	$27.35 - $37.28 $2.14 Million - $2.92 Million	-78,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$26.5 - $38.23 $2.13 Million - $3.07 Million	-80,300 Reduced 50.63%	78,300 $2.72 Million
Q1 2021 May 17, 2021	SELL	$29.83 - $56.81 $19.6 Million - $37.3 Million	-656,000 Reduced 80.53%	158,600 $5.01 Million
Q4 2020 Feb 16, 2021	BUY	$39.12 - $54.99 $25.4 Million - $35.7 Million	649,190 Added 392.47%	814,600 $38.5 Million
Q3 2020 Nov 16, 2020	BUY	$29.21 - $46.58 $4.83 Million - $7.7 Million	165,410 New	165,410 $7.71 Million
Q2 2020 Aug 14, 2020	SELL	$33.67 - $40.0 $28 Million - $33.2 Million	-830,507 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$24.28 - $49.8 $20.2 Million - $41.4 Million	830,507 New	830,507 $29.5 Million
Q2 2019 Aug 14, 2019	SELL	$15.0 - $22.49 $1.88 Million - $2.81 Million	-125,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.02 - $16.74 $1.75 Million - $2.09 Million	125,000 New	125,000 $2.02 Million
Q4 2018 Feb 14, 2019	SELL	$10.95 - $15.44 $1.26 Million - $1.78 Million	-115,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.21 - $16.61 $183,150 - $249,150	15,000 Added 15.0%	115,000 $1.81 Million
Q2 2018 Aug 14, 2018	BUY	$11.13 - $21.86 $1.11 Million - $2.19 Million	100,000 New	100,000 $1.48 Million

Others Institutions Holding ZYME

# of Institutions

Shares Held

296K

Call Options Held

Put Options Held

Strategic Wealth Advisors Group, LLC Sacramento, CA

296K
Shares

$4.34 Million
0.08% of portfolio

View Full List

About Zymeworks Inc.

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $903M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

More about ZYME

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account